Demonstration of adiponectin receptors 1 and 2 mRNA expression in human breast cancer cells.

[1]  M. Dieudonné,et al.  Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. , 2006, Biochemical and biophysical research communications.

[2]  B. Yu,et al.  Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell , 2005, Archives of pharmacal research.

[3]  C. Drevon,et al.  Adiponectin and its receptors are expressed in bone-forming cells. , 2004, Bone.

[4]  C. Mantzoros,et al.  Circulating adiponectin and endometrial cancer risk. , 2004, The Journal of clinical endocrinology and metabolism.

[5]  C. Mantzoros,et al.  Adiponectin and breast cancer risk. , 2004, The Journal of clinical endocrinology and metabolism.

[6]  S. Kihara,et al.  Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[7]  B. Staels,et al.  Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR. , 2004, Biochemical and biophysical research communications.

[8]  D. Eizirik,et al.  Expression of adiponectin receptors in pancreatic beta cells. , 2003, Biochemical and biophysical research communications.

[9]  S. Kihara,et al.  Association of serum adiponectin levels with breast cancer risk. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  Philippe Froguel,et al.  Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.

[11]  Emily White,et al.  Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States) , 2002, Cancer Causes & Control.

[12]  S. Kihara,et al.  Adipocyte-Derived Plasma Protein Adiponectin Acts as a Platelet-Derived Growth Factor-BB–Binding Protein and Regulates Growth Factor–Induced Common Postreceptor Signal in Vascular Smooth Muscle Cell , 2002, Circulation.

[13]  M. Matsuda,et al.  Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.

[14]  P. Scherer,et al.  The adipocyte-secreted protein Acrp30 enhances hepatic insulin action , 2001, Nature Medicine.

[15]  Y. Terauchi,et al.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.

[16]  M. Inoue,et al.  Association of Family History and Other risk factors with Breast Cancer Risk among Japanese Premenopausal and Postmenopausal Women , 2001, Cancer Causes & Control.

[17]  H. Lodish,et al.  Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  H. Adami,et al.  Overweight as an avoidable cause of cancer in Europe , 2001, International journal of cancer.

[19]  S. Kihara,et al.  Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. , 2000, Blood.

[20]  J. Manson,et al.  Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. , 1998, Journal of the National Cancer Institute.

[21]  Y. Nakano,et al.  Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. , 1996, Journal of biochemistry.

[22]  T. Funahashi,et al.  cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.

[23]  P. Strax,et al.  A prospective study of endogenous estrogens and breast cancer in postmenopausal women. , 1995, Journal of the National Cancer Institute.

[24]  M. Pike,et al.  Hormone levels in older women: a study of post-menopausal breast cancer patients and healthy population controls. , 1990, British Journal of Cancer.

[25]  G. Clark,et al.  Serum concentrations of total and non‐protein‐bound oestradiol in patients with breast cancer and in normal controls , 1982, International journal of cancer.

[26]  T. Key,et al.  Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom) , 2004, Cancer Causes & Control.

[27]  M. Dowsett,et al.  A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. , 1997, British Journal of Cancer.

[28]  E. Sterns,et al.  Plasma concentrations of C-19 steroids, estrogens, FSH, LH and prolactin in post-menopausal women with an without breast cancer. , 1981, Oncology.